Form D — Telemachus Therapeutics, Inc.
0002152986-26-000001 · filed Sep 2, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $1,500,000
- Reported amount sold
- $125,000
- Minimum investment
- $50,000
- Investors
- 1
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Telemachus Therapeutics, Inc.
- CIK
- 2152986
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 401 WOODHAVEN DRIVE
WEXFORD, PA 15090 - Phone
- 412-527-6630
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Bozik · Executive OfficerPittsburgh, PA Find on LinkedIn ↗
-
Gregory Hebrank · Executive OfficerGreensburg, PA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗